COMP <GO>
LRN vs CVSA // RETURN ON INVESTED CAPITAL (ROIC)
Stride Inc. (NYSE) VS. Covista Inc. (NYSE) • 15-METRIC TALLY: LRN 8
— CVSA 5
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: LRN
LAST: $78.36 (-2.90%) • MKT CAP: $3.39B
roic
19.40%
LAST: $124.33 (-3.44%) • MKT CAP: $4.36B
roic
14.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LRN VS. CVSA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LRN | CVSA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.20% | 56.90% | -17.70 | CVSA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 19.40% | 14.80% | +4.60 | LRN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.2x | 12.5x | -3.30 | LRN | /valuation <GO> |
| Free Cash Flow Yield | 12.70% | 6.60% | +6.10 | LRN | /fcf-yield <GO> |
| Operating Margin | 15.00% | 19.10% | -4.10 | CVSA | /operating-margins <GO> |
| Net Profit Margin | 12.00% | 13.30% | -1.30 | CVSA | /net-margins <GO> |
| Revenue Growth (YoY) | 17.90% | 12.90% | +5.00 | LRN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.40% | 3.40% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.58 | 4.73 | +0.85 | LRN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | LRN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.8 | 51.9 | -1.10 | CVSA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 1.05 | +0.03 | LRN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.9x | 15.5x | -5.60 | LRN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.39B | $4.36B | -$966.5M | CVSA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LRN REV | CVSA REV | LRN GROSS % | CVSA GROSS % | LRN FCF | CVSA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.41B | $1.79B | 39.2% | 56.9% | $431.0M | $287.6M |
| FY 2024 | $2.04B | $1.58B | 37.4% | 55.9% | $276.5M | $246.9M |
| FY 2023 | $1.84B | $1.45B | — | — | $120.5M | $126.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LRN // BETA 1.08
CVSA // BETA 1.05